Views
1 year ago

Work programme 2017

WC500221614

Theme 4: Contributing to

Theme 4: Contributing to the global regulatory environment Objective 3: Ensure best use of resources through promoting mutual reliance and worksharing Objective 4: Support training and capacity building and promote the EU regulatory model medicines development Main areas of work: work-sharing, information sharing and increasing reliance on European assessments Main areas of work: non-EU regulators' training and capacity building Work programme 2017 EMA/583016/2016 Page 14/123

Multiannual work programme Multiannual work programme outlines the Agency's medium-term objectives and the main initiatives and activities to achieve these. The multiannual objectives come from the Network strategy and describe what the Network as a whole will strive to achieve. The Agency's particular contribution is highlighted through the implementing activities and initiatives that follow each of the objectives. Theme 1: Contributing to human health Objective 1: Focus on key public health priorities including availability of medicines and antimicrobial resistance Area Medium-term objective No Initiative(s) Start End Priority Performance indicator(s) Antimicrobial resistance Promote responsible use of antibiotics in human and veterinary medicine adopting a 'One Health' perspective* 1.1-1 Establish and run cross-Agency task force on antimicrobial resistance Contribute to European and 1.1-2 Implement actions assigned to EMA as international initiatives and part of the third implementation period collaborations in the area of of the TATFAR initiative AMR 1.1-3 Contribute to implementation of the next phase of the EC Action Plan on AMR, the WHO Global action Plan, OIE strategy and other action plans such as the "G8" * Specific initiatives in the veterinary domain are covered under Theme 2: Objective 4. 2015 2020 Critical/ urgent - task force established and running - proposals given/implemented for EMA activities to address antimicrobial resistance 2016 2018 High - number and proportion of TATFAR actions implemented (where EMA has a role) - level of completion of the actions 2016 2018 High - actual contribution to WHO - completion level and/or rate of implementation of actions in the action plan(s) Work programme 2017 EMA/583016/2016 Page 15/123

2017 Work Programme
MHRA powerpoint template - TOPRA
Work Programme 2013 - ECHA - Europa
Work Programme 2011 - ERA - Europa
Monaco 2010 - Drug Information Association
The Case of ESA's General Support Technology Programme (GSTP)
healthpgm_pres_nov2013_en
The 9th TOPRA Annual Symposium 2012 - Human Medicines
VMGN 11 - Veterinary Medicines Directorate - Defra
IFAH-Europe annual report 2006 - Bundesverband für Tiergesundheit
programme activities - European Consortium for Ocean Research ...
How TOPRA in Spain will work - presentation
Carrickmacross Arts Festival 2017 Programme
VMGN 09 - Guidance on Appeals against Regulatory Decisions